naftifine hydrochloride 0.02 MG/MG Topical Gel
naftifine hydrochloride
RxCUI: 1433734
What the CMS Formulary Data Shows for naftifine hydrochloride 0.02 MG/MG Topical Gel
Per the CMS 2026 Part D formulary file, naftifine hydrochloride 0.02 MG/MG Topical Gel (RxNorm concept RXCUI 1433734, generic name naftifine hydrochloride) appears on 35 distinct formulary files spanning 549 Medicare Part D plan offerings - 10.8% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 3.3.
Real-world access to naftifine hydrochloride 0.02 MG/MG Topical Gel depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 2.9% require step therapy. 85.7% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 8,135 Part D beneficiaries filled naftifine hydrochloride 0.02 MG/MG Topical Gel in 2023, with total plan-and-beneficiary spending of $7,385,409 and an average per-beneficiary annual cost of $907.86. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry naftifine hydrochloride 0.02 MG/MG Topical Gel today.
Coverage Details
- Formularies covering
- 35
- Plans covering
- 549
- Coverage rate
- 10.8%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 2.9% of formularies
- Quantity limits
- 85.7% of formularies
2023 Medicare Spending
- Beneficiaries
- 8,135
- Total spending
- $7,385,409
- Avg per beneficiary
- $907.86
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering naftifine hydrochloride 0.02 MG/MG Topical Gel
1 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| HealthSpring TotalCare Plus (HMO D-SNP) | BRAVO HEALTH PENNSYLVANIA, INC. | T3 | No | No | $0 | CT |
Medicare Advantage Plans (MA-PD) Covering naftifine hydrochloride 0.02 MG/MG Topical Gel
99 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| ElderServe MAP (HMO D-SNP) | ELDERSERVE HEALTH, INC. | T1 | No | $0 | NY |
| Cooperative Advantage (HMO D-SNP) | GROUP HEALTH COOPERATIVE OF EAU CLAIRE | T1 | No | $0 | WI |
| Longevity Health Plan (PPO I-SNP) | LONGEVITY HEALTH PLAN OF NEW JERSEY INSURANCE COMP | T1 | No | $0 | NJ |
| Upper Peninsula Health Plan MI Coordinated Health (HMO D-SNP) | UPPER PENINSULA HEALTH PLAN, LLC | T1 | No | $0 | MI |
| CareSource Dual Advantage (HMO D-SNP) | CARESOURCE GEORGIA CO. | T1 | No | $0 | GA |
| HAP CareSource MI Coordinated Health (HMO D-SNP) | HAP CARESOURCE | T1 | No | $0 | MI |
| CareAdvantage (HMO D-SNP) | SAN MATEO HEALTH COMMISSION | T1 | No | $0 | CA |
| Longevity Health Plan (HMO I-SNP) | LONGEVITY HEALTH PLAN OF FLORIDA, INC. | T1 | No | $4.80 | FL |
| Longevity Health Plan (HMO I-SNP) | LONGEVITY HEALTH PLAN OF MICHIGAN, INC. | T1 | No | $8.80 | MI |
| Longevity Health Plan (HMO I-SNP) | LONGEVITY HEALTH PLAN OF ILLINOIS, INC. | T1 | No | $15.20 | IL |
| WellSense Added Value (HMO) | BOSTON MEDICAL CENTER HEALTH PLAN, INC. | T1 | No | $21.70 | NH |
| Longevity Health Plan (HMO I-SNP) | LONGEVITY HEALTH PLAN OF COLORADO, INC. | T1 | No | $35.20 | CO |
| Longevity Health Plan (HMO I-SNP) | LONGEVITY HEALTH PLAN OF NORTH CAROLINA, INC. | T1 | No | $36.20 | NC |
| Longevity Health Plan (PPO I-SNP) | LONGEVITY HEALTH PLAN OF NEW JERSEY INSURANCE COMP | T1 | No | $40.00 | NJ |
| ElderServe Star (HMO I-SNP) | ELDERSERVE HEALTH, INC. | T1 | No | $58.80 | NY |
| Longevity Health Plan (HMO I-SNP) | LONGEVITY HEALTH PLAN OF NEW YORK, INC. | T1 | No | $58.80 | NY |
| HealthSpring TotalCare Plus (HMO D-SNP) | HEALTHSPRING LIFE & HEALTH INSURANCE COMPANY, INC. | T3 | No | $0 | GA |
| HealthSpring TotalCare Plus (HMO D-SNP) | HEALTHSPRING LIFE & HEALTH INSURANCE COMPANY, INC. | T3 | No | $0 | MO |
| HealthSpring TotalCare (HMO D-SNP) | CIGNA HEALTHCARE OF COLORADO, INC. | T3 | No | $0 | CO |
| HealthSpring TotalCare Plus (HMO D-SNP) | CIGNA HEALTHCARE OF COLORADO, INC. | T3 | No | $0 | CO |
| HealthSpring TotalCare (HMO D-SNP) | CIGNA HEALTHCARE OF COLORADO, INC. | T3 | No | $0 | OH |
| HealthSpring TotalCare Plus (HMO D-SNP) | CIGNA HEALTHCARE OF COLORADO, INC. | T3 | No | $0 | OH |
| HealthSpring TotalCare Plus (HMO D-SNP) | BRAVO HEALTH MID-ATLANTIC, INC. | T3 | No | $0 | MD |
| HealthSpring TotalCare Plus (HMO D-SNP) | BRAVO HEALTH PENNSYLVANIA, INC. | T3 | No | $0 | PA |
| HealthSpring TotalCare (HMO D-SNP) | HEALTHSPRING LIFE & HEALTH INSURANCE COMPANY, INC. | T3 | No | $0 | MS |
| HealthSpring TotalCare Plus (HMO D-SNP) | HEALTHSPRING LIFE & HEALTH INSURANCE COMPANY, INC. | T3 | No | $0 | MS |
| HealthSpring TotalCare (HMO D-SNP) | HEALTHSPRING LIFE & HEALTH INSURANCE COMPANY, INC. | T3 | No | $0 | TX |
| HealthSpring TotalCare Plus (HMO D-SNP) | HEALTHSPRING LIFE & HEALTH INSURANCE COMPANY, INC. | T3 | No | $0 | TN |
| HealthSpring TotalCare Plus (HMO D-SNP) | HEALTHSPRING LIFE & HEALTH INSURANCE COMPANY, INC. | T3 | No | $0 | AR |
| HealthSpring TotalCare (HMO D-SNP) | HEALTHSPRING LIFE & HEALTH INSURANCE COMPANY, INC. | T3 | No | $0 | TX |
| HealthSpring TotalCare Plus (HMO D-SNP) | HEALTHSPRING LIFE & HEALTH INSURANCE COMPANY, INC. | T3 | No | $0 | AL |
| HealthSpring TotalCare (HMO D-SNP) | HEALTHSPRING LIFE & HEALTH INSURANCE COMPANY, INC. | T3 | No | $0 | TX |
| HealthSpring TotalCare Plus (HMO D-SNP) | HEALTHSPRING LIFE & HEALTH INSURANCE COMPANY, INC. | T3 | No | $0 | GA |
| HealthSpring TotalCare Plus (HMO D-SNP) | HEALTHSPRING OF FLORIDA, INC. | T3 | No | $0 | FL |
| HealthSpring TotalCare Plus (HMO D-SNP) | HEALTHSPRING OF FLORIDA, INC. | T3 | No | $0 | FL |
| HealthSpring TotalCare Plus (HMO D-SNP) | HEALTHSPRING OF FLORIDA, INC. | T3 | No | $0 | FL |
| HealthSpring TotalCare Plus (HMO D-SNP) | HEALTHSPRING OF FLORIDA, INC. | T3 | No | $0 | FL |
| HealthSpring TotalCare Plus (HMO D-SNP) | HEALTHSPRING OF FLORIDA, INC. | T3 | No | $0 | FL |
| HealthSpring TotalCare Plus (HMO D-SNP) | BRAVO HEALTH PENNSYLVANIA, INC. | T3 | No | $0 | NC |
| HealthSpring TotalCare (HMO D-SNP) | HEALTHSPRING LIFE & HEALTH INSURANCE COMPANY, INC. | T3 | No | $2.60 | MO |
| HealthSpring TotalCare (HMO D-SNP) | HEALTHSPRING LIFE & HEALTH INSURANCE COMPANY, INC. | T3 | No | $3.30 | AL |
| HealthSpring TotalCare (HMO D-SNP) | HEALTHSPRING LIFE & HEALTH INSURANCE COMPANY, INC. | T3 | No | $3.40 | GA |
| HealthSpring TotalCare (HMO D-SNP) | HEALTHSPRING OF FLORIDA, INC. | T3 | No | $4.80 | FL |
| HealthSpring TotalCare (HMO D-SNP) | HEALTHSPRING OF FLORIDA, INC. | T3 | No | $4.80 | FL |
| HealthSpring TotalCare (HMO D-SNP) | HEALTHSPRING OF FLORIDA, INC. | T3 | No | $4.80 | FL |
| HealthSpring TotalCare (HMO D-SNP) | HEALTHSPRING OF FLORIDA, INC. | T3 | No | $4.80 | FL |
| HealthSpring TotalCare (HMO D-SNP) | HEALTHSPRING OF FLORIDA, INC. | T3 | No | $4.80 | FL |
| HealthSpring TotalCare (HMO D-SNP) | HEALTHSPRING LIFE & HEALTH INSURANCE COMPANY, INC. | T3 | No | $8.70 | AR |
| HealthSpring Primary (HMO) | HEALTHSPRING LIFE & HEALTH INSURANCE COMPANY, INC. | T3 | No | $17.70 | TN |
| HealthSpring TotalCare (HMO D-SNP) | BRAVO HEALTH PENNSYLVANIA, INC. | T3 | No | $19.70 | NC |
Frequently Asked Questions
Is naftifine hydrochloride 0.02 MG/MG Topical Gel covered by Medicare Part D?
Yes, naftifine hydrochloride 0.02 MG/MG Topical Gel is covered by 549 Medicare Part D plans (10.8% of all Part D formularies).
What tier is naftifine hydrochloride 0.02 MG/MG Topical Gel on Medicare Part D plans?
naftifine hydrochloride 0.02 MG/MG Topical Gel averages Tier 3.3 across Part D plans, ranging from Tier 1 to Tier 4.
Does naftifine hydrochloride 0.02 MG/MG Topical Gel require prior authorization?
0% of Part D formularies require prior authorization for naftifine hydrochloride 0.02 MG/MG Topical Gel. Step therapy: 2.9%. Quantity limits: 85.7%.
How much does Medicare spend on naftifine hydrochloride 0.02 MG/MG Topical Gel?
In 2023, total Medicare Part D spending on naftifine hydrochloride 0.02 MG/MG Topical Gel was $7,385,409, covering 8,135 beneficiaries. The average spend per beneficiary was $907.86.
Read our methodology - how this data is sourced, computed, and verified.